X0306 4 2017-09-11 0001624326 PAVmed Inc. PAVM 0001665074 Aklog Lishan ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK NY 10165 1 1 1 0 Chairman and CEO 0001665111 HCFP/Capital Partners III LLC ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK NY 10165 0 0 1 0 0001665114 Pavilion Venture Partners LLC ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK NY 10165 0 0 1 0 Common Stock 2017-09-11 4 P 0 300 A 65738 D Common Stock 2017-09-12 4 P 0 100 6.66 A 65838 D Common Stock 2017-09-13 4 P 0 300 A 66138 D Common Stock 285 I By daughter Common Stock 300 I By son Common Stock 5713879 I By HCFP/Capital Partners III LLC Common Stock 2520532 I By Pavilion Venture Partners LLC Common Stock 87020 I By HCFP Inc. Common Stock 125000 I By HCFP/Capital Partners IIIB LLC Common Stock 20000 I By HCFP/AG LLC Warrants 5.00 2017-09-12 4 P 0 200 A 2016-10-28 2022-01-29 Common Stock 200 50300 D Warrants 5.00 2017-09-13 4 P 0 100 2.41 A 2016-10-28 2022-01-29 Common Stock 100 50400 D Warrants 5.00 2016-10-28 2022-01-29 Common Stock 5713879 5713879 I By HCFP/Capital Partners III LLC Warrants 5.00 2016-10-28 2022-01-29 Common Stock 2220532 2220532 I By Pavilion Venture Partners LLC Warrants 5.00 2016-10-28 2022-01-29 Common Stock 387020 387020 I By HCFP Inc. Warrants 5.00 2016-10-28 2022-01-29 Common Stock 125000 125000 I By HCFP/Capital Partners IIIB LLC Warrants 5.00 2016-10-28 2022-01-29 Common Stock 20000 2000 I By HCFP/AG LLC The shares were purchased at a weighted average price of approximately $6.383 per share. These shares were purchased in multiple transactions at prices ranging from $6.35 to $6.45, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. The shares were purchased at a weighted average price of approximately $6.88483 per share. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.03, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. The warrants were purchased at a weighted average price of approximately $2.71 per warrant. These warrants were purchased in multiple transactions at prices ranging from $2.10 to $3.32, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Dr. Aklog is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein. Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein. Dr. Aklog is a controlling shareholder of HCFP Inc., and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein. Dr. Aklog is a member and a co-manager of the entity that acts as sole manager of HCFP/Capital Partners IIIB LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein. Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein. /s/ Dr. Lishan Aklog 2017-09-14 /s/ Dr. Lishan Aklog, as manager of HCFP/Capital Partners III LLC 2017-09-14 /s/ Dr. Lishan Aklog, as manager of Pavilion Venture Partners LLC 2017-09-14